Literature DB >> 16476169

Evaluation of measures to reduce international spread of SARS.

K Glass1, N G Becker.   

Abstract

Mathematical models are used to quantify the effect of border control measures in reducing the international spread of SARS. Border screening is shown to play a relatively minor role in reducing disease spread. Assuming detection rates similar to those reported for arrival screening in Australia, screening can detect up to 10% (95% CI 3-23) of infected travellers, and reduce the probability of a large outbreak by up to 7% (95% CI 2-17). Rapid reductions in the time to diagnosis and effective facilities for the isolation of cases are essential to ensure that there will not be a large outbreak, and each week of delay in responding to imported infection approximately doubles the total number of cases. While the control response is being developed in a currently uninfected region, border screening can provide up to one week's additional time in which to improve methods for early isolation of cases.

Entities:  

Mesh:

Year:  2006        PMID: 16476169      PMCID: PMC2870475          DOI: 10.1017/S0950268806005863

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  12 in total

1.  Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions.

Authors:  Steven Riley; Christophe Fraser; Christl A Donnelly; Azra C Ghani; Laith J Abu-Raddad; Anthony J Hedley; Gabriel M Leung; Lai-Ming Ho; Tai-Hing Lam; Thuan Q Thach; Patsy Chau; King-Pan Chan; Su-Vui Lo; Pak-Yin Leung; Thomas Tsang; William Ho; Koon-Hung Lee; Edith M C Lau; Neil M Ferguson; Roy M Anderson
Journal:  Science       Date:  2003-05-23       Impact factor: 47.728

2.  Planning for epidemics--the lessons of SARS.

Authors:  Robert A Weinstein
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

3.  Extract from SARS in Hong Kong: from experience to action.

Authors: 
Journal:  Aust Health Rev       Date:  2003       Impact factor: 1.990

4.  Controlling emerging infectious diseases like SARS.

Authors:  Niels G Becker; Kathryn Glass; Zhengfeng Li; Geoffrey K Aldis
Journal:  Math Biosci       Date:  2005-02       Impact factor: 2.144

5.  Transmission of the severe acute respiratory syndrome on aircraft.

Authors:  Sonja J Olsen; Hsiao-Ling Chang; Terence Yung-Yan Cheung; Antony Fai-Yu Tang; Tamara L Fisk; Steven Peng-Lim Ooi; Hung-Wei Kuo; Donald Dah-Shyong Jiang; Kow-Tong Chen; Jim Lando; Kwo-Hsiung Hsu; Tzay-Jinn Chen; Scott F Dowell
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

6.  SARS preventive and risk behaviours of Hong Kong air travellers.

Authors:  Joseph T F Lau; Xilin Yang; Hiyi Tsui; Ellie Pang; Jean H Kim
Journal:  Epidemiol Infect       Date:  2004-08       Impact factor: 2.451

7.  Border screening for SARS in Australia: what has been learnt?

Authors:  Gina Samaan; Mahomed Patel; Jenean Spencer; Leslee Roberts
Journal:  Med J Aust       Date:  2004-03-01       Impact factor: 7.738

8.  Public health interventions and SARS spread, 2003.

Authors:  David M Bell
Journal:  Emerg Infect Dis       Date:  2004-11       Impact factor: 6.883

9.  Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong.

Authors:  Christl A Donnelly; Azra C Ghani; Gabriel M Leung; Anthony J Hedley; Christophe Fraser; Steven Riley; Laith J Abu-Raddad; Lai-Ming Ho; Thuan-Quoc Thach; Patsy Chau; King-Pan Chan; Tai-Hing Lam; Lai-Yin Tse; Thomas Tsang; Shao-Haei Liu; James H B Kong; Edith M C Lau; Neil M Ferguson; Roy M Anderson
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

10.  Border screening for SARS.

Authors:  Nicola Petrosillo; Vincenzo Puro; Giuseppe Ippolito
Journal:  Med J Aust       Date:  2004-06-07       Impact factor: 7.738

View more
  8 in total

Review 1.  Physical interventions to interrupt or reduce the spread of respiratory viruses.

Authors:  Tom Jefferson; Chris B Del Mar; Liz Dooley; Eliana Ferroni; Lubna A Al-Ansary; Ghada A Bawazeer; Mieke L van Driel; Sreekumaran Nair; Mark A Jones; Sarah Thorning; John M Conly
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

2.  Behavioural responses to influenza pandemics: what do we know?

Authors:  Marta Balinska; Caterina Rizzo
Journal:  PLoS Curr       Date:  2009-09-09

3.  Cochrane Review: Interventions for the interruption or reduction of the spread of respiratory viruses.

Authors:  Tom Jefferson; Ruth Foxlee; Chris Del Mar; Liz Dooley; Eliana Ferroni; Bill Hewak; Adi Prabhala; Sreekumaran Nair; Alessandro Rivetti
Journal:  Evid Based Child Health       Date:  2008-12-10

4.  Fever screening during the influenza (H1N1-2009) pandemic at Narita International Airport, Japan.

Authors:  Hiroshi Nishiura; Kazuko Kamiya
Journal:  BMC Infect Dis       Date:  2011-05-03       Impact factor: 3.090

Review 5.  Entry screening for infectious diseases in humans.

Authors:  Linda A Selvey; Catarina Antão; Robert Hall
Journal:  Emerg Infect Dis       Date:  2015-02       Impact factor: 6.883

6.  Australian Quarantine Policy: From Centralization to Coordination with Mid-Pandemic COVID-19 Shifts.

Authors:  Kim Moloney; Susan Moloney
Journal:  Public Adm Rev       Date:  2020-06-29

7.  Travel-related control measures to contain the COVID-19 pandemic: an evidence map.

Authors:  Ani Movsisyan; Jacob Burns; Renke Biallas; Michaela Coenen; Karin Geffert; Olaf Horstick; Irma Klerings; Lisa Maria Pfadenhauer; Peter von Philipsborn; Kerstin Sell; Brigitte Strahwald; Jan M Stratil; Stephan Voss; Eva Rehfuess
Journal:  BMJ Open       Date:  2021-04-09       Impact factor: 2.692

8.  Physical interventions to interrupt or reduce the spread of respiratory viruses.

Authors:  Tom Jefferson; Chris B Del Mar; Liz Dooley; Eliana Ferroni; Lubna A Al-Ansary; Ghada A Bawazeer; Mieke L van Driel; Mark A Jones; Sarah Thorning; Elaine M Beller; Justin Clark; Tammy C Hoffmann; Paul P Glasziou; John M Conly
Journal:  Cochrane Database Syst Rev       Date:  2020-11-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.